Mereo BioPharma

Lack of early win for Ultragenyx’s bone disorder med dents stock

Analysts are keeping faith in Ultragenyx’s brittle bone disease medicine despite the monoclonal antibody failing to score an early outright trial win.

James Waldron Jul 10, 2025 8:04am

broken bone fracture break x ray skeleton

Ultragenyx, Mereo's brittle bone drug sustains fracture rate cut

Jun 12, 2024 8:55am

Ultragenyx, Mereo's bone disease med cuts fractures by 67%

Oct 16, 2023 12:39pm

Ultragenyx brittle bone drug causes fast improvements in phase 2

Jun 6, 2023 7:42am

Mereo gives in to investor demands, hands over board seats

Oct 28, 2022 10:52am

head to head against clash football helmets fight combat

Activist investor snaps Mereo's olive branch as proxy feud looms

Sep 26, 2022 9:00am